That would be insanely good! I mean lets just assu
Post# of 2146
I mean lets just assume the 12 new products simply double their cash flow ....looking at maybe $12 million in PCF on generics alone.
Poof goes NJEDA debt!
ART funded internally if they want.
Also, they fully utilize their manufacturing facilities.